Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Bisalbuminemia associated with monoclonal gammopathy in a patient with lymphoma: A Case Report

Breadcrumb

  • Home
  • Bisalbuminemia Associated With Monoclonal Gammopathy In a Patient With Lymphoma: A Case Report
  • Bisalbuminemia associated with monoclonal gammopathy in a patient with lymphoma: A Case Report

Yasmina Hadoui *, Nada Khlifi Tagzouti, Saliha Chellak and Abderrahmane Boukhira

Laboratory of Biochemistry, Military Hospital Avicenna of Marrakech, Faculty of Medicine and Pharmacy of Marrakech, University of CADI AYYAD of Marrakech. Morocco.

Research Article
GSC Biological and Pharmaceutical Sciences, 2026, 34(01), 214-217.
Article DOI: 10.30574/gscbps.2026.34.1.0034
DOI url: https://doi.org/10.30574/gscbps.2026.34.1.0034

Received on 18 December 2025; revised on 27 January 2026; accepted on 29 January 2026

Bisalbuminemia is a rare electrophoretic abnormality characterized by two distinct albumin fractions on serum protein electrophoresis [4,5]. Although it is most often hereditary, acquired forms may occur in various pathological conditions. Its association with lymphoproliferative disorders and monoclonal gammopathy is uncommon and poorly documented [7]. We report the case of a 32-year-old man diagnosed with lymphoma, whose serum protein electrophoresis revealed marked bisalbuminemia associated with an IgG kappa monoclonal spike. Immunotyping confirmed the monoclonal nature of the gamma peak [2,7]. Radiological investigations identified multiple lymphadenopathies and secondary neurological involvement. This case highlights the analytical significance of bisalbuminemia in high-resolution electrophoresis and discusses its possible pathophysiological mechanisms in lymphoma [4,6]. Awareness of this rare electrophoretic pattern is essential to avoid misinterpretation and ensure accurate detection of clinically significant monoclonal components [2,6].

Bisalbuminemia; Serum protein electrophoresis; Lymphoma; Monoclonal gammopathy; IgG kappa

https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2026-…

Preview Article PDF

Yasmina Hadoui, Nada Khlifi Tagzouti, Saliha Chellak and Abderrahmane Boukhira. Bisalbuminemia associated with monoclonal gammopathy in a patient with lymphoma: A Case Report. GSC Biological and Pharmaceutical Sciences, 2026, 34(1), 214-217. Article DOI: https://doi.org/10.30574/gscbps.2026.34.1.0034


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution